The FDA was asked recently by the House Energy and Commerce Committee to turn over the results of the so-called Seas study from Oxford University. The results of this study shocked the medical society as well as investors.

The researchers from Oxford University found that risk of cancer in a group of patients taking Vytorin was unexpectedly higher than in the control group. And yet when the FDA submitted the results, it stated that the link between Vytorin and higher cancer risks wasn’t there. Funny though, how the study was submitted to the FDA but never to the House Commerce Committee, which investigates the safety of prescription drugs.

So, can we fully trust the FDA? It seems the answer is obvious.

health, Vytorin, cancer

Technorati Tags: health, Vytorin, cancer

You may also find interesting

• How Does Low Testosterone Affect Women?
• How often should you have s.e.x.?
• Seafood Selection and Your Health
• Chronic Stress Can Lower Your Testosterone

This entry was posted on Saturday, August 2nd, 2008 at 4:38 pm and is filed under Do you know, General health. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.